Publikationen von F. Holsboer

Almeida, O. F. X.; Condé, G. L.; Chrochemore, C.; Demeneix, B. A.; Fischer, D.; Hassan, A. H. S.; Meyer, M.; Holsboer, F.; Michaelidis, T. M.: Subtle shifts in the ratio between pro- and antiapoptoic molecules after activation of corticosteroid receptors decide neuronal fate. FASEB Journal 14, S. 779 - 790 (2000)

Auer, D. P.; Pütz, B.; Kraft, E.; Lipinski, B.; Schill, J.; Holsboer, F.: Reduced glutamate in the anterior cingulate cortex in depression: An in vivo proton magnetic resonance spectroscopy study. Biological Psychiatry 47, S. 305 - 313 (2000)

Do, K. Q.; Trabesinger, A.; Kirsten-Krüger, M.; Lauer, C. J.; Dydak, U.; Hell, D.; Holsboer, F.; Boesiger, P.; Cuénod, M.: Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. European Journal of Neuroscience 12, S. 3721 - 3728 (2000)

Hatzinger, M.; Wotjak, C. T.; Naruo, T.; Simchen, R.; Keck, M. E.; Landgraf, R.; Holsboer, F.; Neumann, I. D.: Endogenous vasopressin contributes to hypothalamic-pituitary-adrenocortical alterations in aged rats. Journal of Endocrinology 164, S. 197 - 205 (2000)

Hermann, B.; Landgraf, R.; Keck, M. E.; Wigger, A.; Morrow, A. L.; Ströhle, A.; Holsboer, F.; Rupprecht, R.: Pharmacological characterisation of cortical gamma-aminobutyric acid type A (GABA-A) receptors in two wistar rat lines selectively bred for high- and low-anxiety-treated behavior. World Journal of Biological Psychiatry 1, S. 137 - 143 (2000)

Herr, A. S.; Wochnik, G. M.; Rosenhagen, M. C.; Holsboer, F.; Rein, T.: Rifampicin is not an activator of glucocorticoid receptor. Molecular Pharmacology 57, S. 732 - 737 (2000)

Heuser, I.; Deuschle, M.; Weber, B.; Stalla, G. K.; Holsboer, F.: Increased activity of the hypothalamus-pituitary-adrenal system after treatment with the mineralocorticoid receptor antagonist spironolactone. Psychoneuroendocrinology 25, S. 513 - 518 (2000)

Holsboer, F.: The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23, S. 477 - 501 (2000)

Holsboer, F.: The corticosterone synthesis inhibitor metyrapone prevents hypoxia/ischemia-induced loss of synaptic function in the rat hippocampus. Editorial. Stroke 31, S. 1171 - 1172 (2000)

Hrabé de Angelis, M.; Flaswinkel, H.; Fuchs, H.; Rathkolb, B.; Soewarto, D.; Marschall, S.; Heffner, S.; Pargent, W.; Wuensch, K.; Jung, M. et al.; Reis, A.; Richter, R.; Alessandrini, F.; Jakob, T.; Fuchs, E.; Kolb, H.; Kremmer, E.; Schaeble, K.; Rollinski, B.; Roscher, A.; Peters, C.; Meitinger, T.; Strom, T.; Steckler, T.; Holsboer, F.; Klopstock, T.; Gekeler, F.; Schindewolf, C.; Jung, T.; Avraham, K.; Behrendt, H.; Ring, J.; Zimmer, A.; Schughart, K.; Pfeffer, K.; Wolf, E.; Balling, R.: Genome-wide, large-scale production of mutant mice by NEU mutagenesis. Nature Genetics 25, S. 444 - 447 (2000)

Keck, M. E.; Hatzinger, M.; Wotjak, C. T.; Landgraf, R.; Holsboer, F.; Neumann, I. D.: Ageing alters intrahypothalamic release patterns of vasopressin and oxytocin in rats. European Journal of Neuroscience 12, S. 1487 - 1494 (2000)

Keck, M. E.; Sillaber, I.; Ebner, K.; Welt, T.; Toschi, N.; Kaehler, S. T.; Singewald, N.; Philippu, A.; Elbel, G. K.; Wotjak, C. T. et al.; Holsboer, F.; Landgraf, R.; Engelmann, M.: Acute transcranial magnetic stimulation of frontal brain regions selectively modulates the release of vasopressin, biogenic amines and amono acids in the rat brain. European Journal of Neuroscience 12, S. 3713 - 3720 (2000)

Kellner, M.; Wiedemann, K.; Yassouridis, A.; Levengood, R.; Guo, L. S.; Holsboer, F.; Yehuda, R.: Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder. Biological Psychiatry 47, S. 107 - 111 (2000)

Kovalovsky, D.; Refojo, D.; Holsboer, F.; Arzt, E.: Molecular mechanisms and TH1/TH2 pathways in corticosteroid regulation of cytokine production. Journal of Neuroimmunology 109, S. 23 - 29 (2000)

Kümpfel, T.; Then Bergh, F.; Pollmächer, T.; Holsboer, F.; Trenkwalder, C.: Acute effects of interferon beta-1a on plasma cytokine levels in patients with MS. Neurology 55, S. 1231 - 1233 (2000)

Linthorst, A. C. E.; Flachskamm, C.; Barden, N.; Holsboer, F.; Reul, J. M. H. M.: Glucocorticoid receptor impairment alters CNS responses to a psychological stressor: An in vivo microdialysis study in transgenic mice. European Journal of Neuroscience 12, S. 283 - 291 (2000)

Müller, M. B.; Keck, M. E.; Zimmermann, S.; Holsboer, F.; Wurst, W.: Disruption of feeding behavior in CRH receptor I-deficient mice is dependent on glucocorticoids. NeuroReport 11, S. 1963 - 1966 (2000)

Müller, M. B.; Landgraf, R.; Preil, J.; Sillaber, I.; Kresse, A. E.; Keck, M. E.; Zimmermann, S.; Holsboer, F.; Wurst, W.: Selective activation of the hypothalamic vasopressinergic system in mice deficient for the corticotropin-releasing hormone receptor 1 is dependent on glucocorticoids. Endocrinology 141, S. 4262 - 4269 (2000)

Mullington, J.; Korth, C.; Hermann, D. M.; Orth, A.; Galanos, C.; Holsboer, F.; Pollmächer, T.: Dose-dependent effects of endotoxin on human sleep. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 278, S. R 947 - R 955 (2000)

Neumann, I. D.; Wigger, A.; Torner, L.; Holsboer, F.; Landgraf, R.: Brain oxytocin inhibits basal and stress-induced activity of the hypothalamo-pituitary-adrenal axis in male and female rats: partial action within the paraventricular nucleus. Journal of Neuroendocrinology 12, S. 235 - 243 (2000)